After a 40% YTD plunge, UnitedHealth is deeply oversold and undervalued. All the bad news is priced in, creating a compelling ...

UnitedHealth Group is juggling regulatory headaches and financial setbacks while trying to pivot back to stability and growth ...

UnitedHealth Group (UNH) closed the most recent trading day at $300.58, moving -1.16% from the previous trading session. This change lagged the S&P 500's daily gain of 0.14%. Meanwhile, the Dow gained ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

UnitedHealth Group Inc. UNH is currently navigating a challenging healthcare landscape, with its Medicare Advantage business ...

UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across the sector.